Total Funding
61
52
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
16006
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
- Peter Emtage: Founder & CEOPast Role: Kite Pharma, Global Head of Cell Therapy
Zack McNealy: Chief Financial OfficerPast Role: Versant Ventures, Vice President-Finance
About the Company
Santa Ana Bio is a biotechnology company that leverages deep cell profiling technologies to design precision biologics in the autoimmune space. The company utilizes multi-omics platforms and antibody engineering to develop targeted therapies for patients with autoimmune and inflammatory diseases.
